Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point of Care Diagnostics | Digital Health | $45.4 Bn | 7.4% |
Named as key players in the same markets as Ortho Clinical Diagnostics (number of shared markets).
Becton, Dickinson and Company (BD)2 shared markets
bioMérieux SA2 shared markets
Roche Diagnostics2 shared markets
Siemens Healthineers2 shared markets
Cepheid1 shared market
Danaher Corporation1 shared market
HemoCue (a Danaher company)1 shared market
Search all reports for Ortho Clinical Diagnostics All companies